GSK’s ViiV Healthcare has shared clinical data on three potential long-acting HIV treatments, providing a look at how its ...

Coulter Partners, the global expert building leadership teams for Health, Science and Technology innovation businesses, ...

The global nicotine gums and mints market is projected to reach approximately USD 1,536.2 million by the end of 2024, with a ...

Two conferences were held in Hanoi and Ho Chi Minh City in early March to discuss shingles in comorbid patients.

Prevalence rates of what GSK calls "deviant" sexual behaviours caused by the drugs are unknown and tend to be under-reported ...

The company will publish its Full-Year 2024 financial results on March 26, 2025. On the reporting date, BioVersys will issue a press release at 7:00 AM CET.

Phil Stevens, from Hampshire, said he developed an addiction to gambling and spending after taking prescription medication for restless leg syndrome (RLS). The 66-year-old has said he is now reluctant ...

The role of AI in supply chain management proved to be the focal issue at the recent 2025 Clinical Trial Supply Europe ...

It is often said that true development lies at the intersection of technology and business understanding. For nearly two ...

Five years after the start of the pandemic, the fight over who owns the underlying technologies that made the Covid-19 ...

Life science companies developing bird flu vaccines are gaining attention as the avian influenza subtype H5N1 becomes an ...